Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc.
CIK 0001369786 · Pharmaceutical Preparations
Z″ MIDDLE ZONE
Z′ 2.04
Net margin
-6.9%
as of 2015-12-31
Operating margin
-14.0%
as of 2015-12-31
Revenue YoY growth
10.1%
as of 2015-12-31
Provenance: Sagent Pharmaceuticals, Inc.’s most recent Revenue
$318,296,000
- Filing
- 0001193125-16-495377 (10-K)
- Period
- 2015-01-01 to 2015-12-31
- XBRL tag
- us-gaap:SalesRevenueGoodsNet
- Context
- eol_PE715633--1510-K0011_STD_365_20151231_0
- Mapping
- seed · confidence 1.00